Want to thrive in an AI-first world? Our FREE Survival Skills Series gives you new tools to add to your kit.

AI is already reshaping hiring and talent development. Download the State of Tech Talent 2026 for global insights on what's working.



    Begin your learning Pathway

    AI Fundamentals

    Take individual courses or combine them to build end-to-end AI capability for the modern workplace.



    Begin your learning Pathway

    AI Data Analytics

    Take individual courses or combine them to master the tools and methodologies that power modern AI data analytics.



    Begin your learning Pathway

    AI & Machine Learning

    Take individual courses or combine them to master the tools and methodologies that power production-grade AI applications.



    Begin your learning Pathway

    AI Product Management

    Take individual courses or combine them to master the frameworks and methodologies that power successful AI-driven products.



    Begin your learning Pathway

    AI Software Engineering

    Take individual courses or combine them to master the complete AI software engineering stack.



    Begin your learning Pathway

    AI Experience & Design

    Take individual courses or combine them to master the tools and methodologies that power modern AI product design.

    Get More Info
    Dr. Antoni Ribas Photo

    Dr. Antoni Ribas

    Antoni Ribas, M.D., Ph.D. is a Professor of Medicine, Professor of Surgery, and Professor of Molecular and Medical Pharmacology at the University of California Los Angeles (UCLA). He is the Director of the Tumor Immunology Program at the Jonsson Comprehensive Cancer Center (JCCC), Vice-President of the Society for Melanoma Research (SMR) and the Chair of the Melanoma Committee at SWOG. He trained at the University of Barcelona, Spain, with postdoctoral research and clinical fellowship at UCLA. Dr. Ribas is an elected member of the American Society of Clinical Investigation (ASCI). He has published over 200 manuscripts on laboratory and clinical research in malignant melanoma. As a physician-scientist, Dr. Ribas has a NIH and California State-funded laboratory where he conducts research focusing on adoptive cell transfer with T cell receptor (TCR) engineered lymphocytes, anti-CTLA4 antibodies, anti-PD-1 antibodies, BRAF and MEK-targeted therapies.

    Coming up near you

    Want to teach at ga?

    Join our global community of instructors and help shape the next generation of industry leaders — while moving your own career forward with proven subject matter expertise, leadership experience, and public speaking skills. Teach online or on campus, full-time
or part-time.

    Learn More